Do elevated urinary adipic and suberic acids indicate increased omega-oxidation?

Urinary organic acid analysis frequently evaluates dicarboxylic acids to assess systemic metabolic efficiency. Elevated levels of adipic (C6) and suberic (C8) acids serve as sensitive, established indicators of alterations in cellular fatty acid processing.

Biochemical mechanisms of metabolic shunting

• Compensatory pathways: Under normal physiological conditions, long-chain fatty acids undergo mitochondrial beta-oxidation to generate acetyl-CoA for cellular energy.
• Microsomal omega-oxidation: When mitochondrial beta-oxidation is impaired or overloaded, accumulated fatty acids are shunted to the endoplasmic reticulum. Here, microsomal omega-oxidation converts the terminal methyl group of the fatty acids into a carboxyl group, forming dicarboxylic acids.
• Peroxisomal chain-shortening: These long-chain dicarboxylic acids undergo peroxisomal beta-oxidation, shortening them to adipic and suberic acids. Because the body cannot easily metabolize these medium-chain dicarboxylic acids further, they spill into the urine as direct biomarkers of increased omega-oxidation.

Clinical drivers of mitochondrial inefficiency

• Primary genetic defects: Classic pathologies like medium-chain acyl-CoA dehydrogenase (MCAD) deficiency prevent normal mitochondrial breakdown, forcing alternative pathway utilization.
• Secondary metabolic stressors: Acquired mitochondrial inefficiency can stem from carnitine deficiency, riboflavin (B2) depletion (a critical cofactor for FAD-dependent acyl-CoA dehydrogenases), prolonged fasting, or high-fat ketogenic diets that saturate mitochondrial capacity.

Bottom line

• Elevated urinary adipic and suberic acids are robust biomarkers indicating that mitochondrial beta-oxidation is impaired or saturated, triggering a compensatory metabolic shift toward microsomal omega-oxidation and peroxisomal processing.